nodes	percent_of_prediction	percent_of_DWPC	metapath
Isosorbide Mononitrate—CYP3A4—Temozolomide—malignant glioma	0.32	1	CbGbCtD
Isosorbide Mononitrate—Vasospasm—Carmustine—malignant glioma	0.0152	0.0296	CcSEcCtD
Isosorbide Mononitrate—Paresis—Temozolomide—malignant glioma	0.0138	0.0267	CcSEcCtD
Isosorbide Mononitrate—Lung infiltration—Carmustine—malignant glioma	0.0111	0.0215	CcSEcCtD
Isosorbide Mononitrate—Disorder sight—Temozolomide—malignant glioma	0.0106	0.0205	CcSEcCtD
Isosorbide Mononitrate—GUCY1A3—retina—malignant glioma	0.0101	0.0757	CbGeAlD
Isosorbide Mononitrate—GUCY1B3—retina—malignant glioma	0.0101	0.0752	CbGeAlD
Isosorbide Mononitrate—GUCY1A3—telencephalon—malignant glioma	0.00932	0.0697	CbGeAlD
Isosorbide Mononitrate—GUCY1B3—telencephalon—malignant glioma	0.00926	0.0692	CbGeAlD
Isosorbide Mononitrate—Cerebration impaired—Temozolomide—malignant glioma	0.00855	0.0166	CcSEcCtD
Isosorbide Mononitrate—Haemorrhoids—Temozolomide—malignant glioma	0.00855	0.0166	CcSEcCtD
Isosorbide Mononitrate—GUCY1A2—central nervous system—malignant glioma	0.00841	0.0629	CbGeAlD
Isosorbide Mononitrate—GUCY1A2—cerebellum—malignant glioma	0.00822	0.0615	CbGeAlD
Isosorbide Mononitrate—Tooth disorder—Temozolomide—malignant glioma	0.00775	0.015	CcSEcCtD
Isosorbide Mononitrate—Hypokinesia—Carmustine—malignant glioma	0.00771	0.015	CcSEcCtD
Isosorbide Mononitrate—Digestion impaired—Temozolomide—malignant glioma	0.00752	0.0146	CcSEcCtD
Isosorbide Mononitrate—GUCY1A3—medulla oblongata—malignant glioma	0.00733	0.0547	CbGeAlD
Isosorbide Mononitrate—GUCY1B3—medulla oblongata—malignant glioma	0.00727	0.0543	CbGeAlD
Isosorbide Mononitrate—Influenza-like symptoms—Temozolomide—malignant glioma	0.00704	0.0137	CcSEcCtD
Isosorbide Mononitrate—GUCY1A3—midbrain—malignant glioma	0.0067	0.05	CbGeAlD
Isosorbide Mononitrate—GUCY1A2—brain—malignant glioma	0.00668	0.0499	CbGeAlD
Isosorbide Mononitrate—GUCY1B3—midbrain—malignant glioma	0.00665	0.0497	CbGeAlD
Isosorbide Mononitrate—GUCY1A3—spinal cord—malignant glioma	0.00653	0.0488	CbGeAlD
Isosorbide Mononitrate—GUCY1B3—spinal cord—malignant glioma	0.00648	0.0485	CbGeAlD
Isosorbide Mononitrate—Coagulopathy—Temozolomide—malignant glioma	0.00646	0.0125	CcSEcCtD
Isosorbide Mononitrate—Rigors—Temozolomide—malignant glioma	0.00616	0.0119	CcSEcCtD
Isosorbide Mononitrate—Gamma-glutamyltransferase increased—Temozolomide—malignant glioma	0.00611	0.0119	CcSEcCtD
Isosorbide Mononitrate—Disturbance in attention—Temozolomide—malignant glioma	0.0058	0.0113	CcSEcCtD
Isosorbide Mononitrate—Breast pain—Temozolomide—malignant glioma	0.00576	0.0112	CcSEcCtD
Isosorbide Mononitrate—Viral infection—Temozolomide—malignant glioma	0.00557	0.0108	CcSEcCtD
Isosorbide Mononitrate—Leukocytosis—Carmustine—malignant glioma	0.00554	0.0107	CcSEcCtD
Isosorbide Mononitrate—GUCY1A3—central nervous system—malignant glioma	0.0053	0.0396	CbGeAlD
Isosorbide Mononitrate—Coordination abnormal—Carmustine—malignant glioma	0.0053	0.0103	CcSEcCtD
Isosorbide Mononitrate—Neck pain—Carmustine—malignant glioma	0.00527	0.0102	CcSEcCtD
Isosorbide Mononitrate—GUCY1B3—central nervous system—malignant glioma	0.00526	0.0393	CbGeAlD
Isosorbide Mononitrate—GUCY1A3—cerebellum—malignant glioma	0.00518	0.0387	CbGeAlD
Isosorbide Mononitrate—GUCY1B3—cerebellum—malignant glioma	0.00514	0.0384	CbGeAlD
Isosorbide Mononitrate—Coordination abnormal—Temozolomide—malignant glioma	0.00512	0.00993	CcSEcCtD
Isosorbide Mononitrate—Musculoskeletal pain—Temozolomide—malignant glioma	0.00509	0.00987	CcSEcCtD
Isosorbide Mononitrate—Candida infection—Carmustine—malignant glioma	0.00497	0.00964	CcSEcCtD
Isosorbide Mononitrate—Influenza like illness—Temozolomide—malignant glioma	0.00488	0.00947	CcSEcCtD
Isosorbide Mononitrate—Candida infection—Temozolomide—malignant glioma	0.0048	0.00931	CcSEcCtD
Isosorbide Mononitrate—Abnormal vision—Carmustine—malignant glioma	0.00454	0.0088	CcSEcCtD
Isosorbide Mononitrate—Mental disability—Carmustine—malignant glioma	0.00452	0.00876	CcSEcCtD
Isosorbide Mononitrate—Abnormal vision—Temozolomide—malignant glioma	0.00439	0.00851	CcSEcCtD
Isosorbide Mononitrate—Mental disability—Temozolomide—malignant glioma	0.00436	0.00847	CcSEcCtD
Isosorbide Mononitrate—Diabetes mellitus—Carmustine—malignant glioma	0.00434	0.00843	CcSEcCtD
Isosorbide Mononitrate—Ear pain—Temozolomide—malignant glioma	0.00428	0.0083	CcSEcCtD
Isosorbide Mononitrate—GUCY1A3—brain—malignant glioma	0.00421	0.0314	CbGeAlD
Isosorbide Mononitrate—GUCY1B3—brain—malignant glioma	0.00418	0.0312	CbGeAlD
Isosorbide Mononitrate—Vascular purpura—Temozolomide—malignant glioma	0.00408	0.00792	CcSEcCtD
Isosorbide Mononitrate—Amnesia—Carmustine—malignant glioma	0.00402	0.0078	CcSEcCtD
Isosorbide Mononitrate—Nasal congestion—Temozolomide—malignant glioma	0.00401	0.00777	CcSEcCtD
Isosorbide Mononitrate—Hot flush—Temozolomide—malignant glioma	0.0039	0.00757	CcSEcCtD
Isosorbide Mononitrate—Amnesia—Temozolomide—malignant glioma	0.00388	0.00754	CcSEcCtD
Isosorbide Mononitrate—Menopausal symptoms—Temozolomide—malignant glioma	0.00387	0.00751	CcSEcCtD
Isosorbide Mononitrate—Thirst—Temozolomide—malignant glioma	0.00384	0.00744	CcSEcCtD
Isosorbide Mononitrate—Purpura—Temozolomide—malignant glioma	0.00379	0.00735	CcSEcCtD
Isosorbide Mononitrate—Diplopia—Carmustine—malignant glioma	0.00378	0.00733	CcSEcCtD
Isosorbide Mononitrate—Diplopia—Temozolomide—malignant glioma	0.00365	0.00708	CcSEcCtD
Isosorbide Mononitrate—Affect lability—Temozolomide—malignant glioma	0.00359	0.00697	CcSEcCtD
Isosorbide Mononitrate—Mood swings—Temozolomide—malignant glioma	0.00346	0.00671	CcSEcCtD
Isosorbide Mononitrate—Hypokalaemia—Carmustine—malignant glioma	0.00344	0.00667	CcSEcCtD
Isosorbide Mononitrate—Muscular weakness—Carmustine—malignant glioma	0.00333	0.00646	CcSEcCtD
Isosorbide Mononitrate—Hypokalaemia—Temozolomide—malignant glioma	0.00332	0.00644	CcSEcCtD
Isosorbide Mononitrate—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00329	0.00638	CcSEcCtD
Isosorbide Mononitrate—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00322	0.00625	CcSEcCtD
Isosorbide Mononitrate—Muscular weakness—Temozolomide—malignant glioma	0.00322	0.00625	CcSEcCtD
Isosorbide Mononitrate—Sweating increased—Temozolomide—malignant glioma	0.00307	0.00596	CcSEcCtD
Isosorbide Mononitrate—Bronchitis—Temozolomide—malignant glioma	0.00303	0.00589	CcSEcCtD
Isosorbide Mononitrate—Dysuria—Temozolomide—malignant glioma	0.00295	0.00572	CcSEcCtD
Isosorbide Mononitrate—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00293	0.00569	CcSEcCtD
Isosorbide Mononitrate—Pneumonia—Carmustine—malignant glioma	0.00293	0.00568	CcSEcCtD
Isosorbide Mononitrate—Pollakiuria—Temozolomide—malignant glioma	0.00291	0.00565	CcSEcCtD
Isosorbide Mononitrate—Erectile dysfunction—Temozolomide—malignant glioma	0.00291	0.00564	CcSEcCtD
Isosorbide Mononitrate—Weight increased—Temozolomide—malignant glioma	0.00287	0.00557	CcSEcCtD
Isosorbide Mononitrate—Weight decreased—Temozolomide—malignant glioma	0.00285	0.00554	CcSEcCtD
Isosorbide Mononitrate—Neuropathy peripheral—Carmustine—malignant glioma	0.00285	0.00554	CcSEcCtD
Isosorbide Mononitrate—Urinary tract infection—Carmustine—malignant glioma	0.00283	0.00549	CcSEcCtD
Isosorbide Mononitrate—Pneumonia—Temozolomide—malignant glioma	0.00283	0.00549	CcSEcCtD
Isosorbide Mononitrate—Neuropathy peripheral—Temozolomide—malignant glioma	0.00276	0.00535	CcSEcCtD
Isosorbide Mononitrate—Urinary tract infection—Temozolomide—malignant glioma	0.00273	0.0053	CcSEcCtD
Isosorbide Mononitrate—Sinusitis—Temozolomide—malignant glioma	0.00264	0.00512	CcSEcCtD
Isosorbide Mononitrate—Haemoglobin—Carmustine—malignant glioma	0.00263	0.0051	CcSEcCtD
Isosorbide Mononitrate—Haemorrhage—Carmustine—malignant glioma	0.00261	0.00507	CcSEcCtD
Isosorbide Mononitrate—Hypoaesthesia—Carmustine—malignant glioma	0.0026	0.00504	CcSEcCtD
Isosorbide Mononitrate—Oedema peripheral—Carmustine—malignant glioma	0.00257	0.00499	CcSEcCtD
Isosorbide Mononitrate—Haemoglobin—Temozolomide—malignant glioma	0.00254	0.00492	CcSEcCtD
Isosorbide Mononitrate—Haemorrhage—Temozolomide—malignant glioma	0.00252	0.0049	CcSEcCtD
Isosorbide Mononitrate—Visual impairment—Carmustine—malignant glioma	0.00252	0.00489	CcSEcCtD
Isosorbide Mononitrate—Hypoaesthesia—Temozolomide—malignant glioma	0.00251	0.00487	CcSEcCtD
Isosorbide Mononitrate—Pharyngitis—Temozolomide—malignant glioma	0.00251	0.00486	CcSEcCtD
Isosorbide Mononitrate—Urinary tract disorder—Temozolomide—malignant glioma	0.00249	0.00484	CcSEcCtD
Isosorbide Mononitrate—Oedema peripheral—Temozolomide—malignant glioma	0.00249	0.00483	CcSEcCtD
Isosorbide Mononitrate—Urethral disorder—Temozolomide—malignant glioma	0.00248	0.0048	CcSEcCtD
Isosorbide Mononitrate—Visual impairment—Temozolomide—malignant glioma	0.00243	0.00472	CcSEcCtD
Isosorbide Mononitrate—Flushing—Carmustine—malignant glioma	0.00242	0.0047	CcSEcCtD
Isosorbide Mononitrate—Tinnitus—Temozolomide—malignant glioma	0.00235	0.00457	CcSEcCtD
Isosorbide Mononitrate—Flushing—Temozolomide—malignant glioma	0.00234	0.00455	CcSEcCtD
Isosorbide Mononitrate—Cardiac disorder—Temozolomide—malignant glioma	0.00234	0.00455	CcSEcCtD
Isosorbide Mononitrate—Arrhythmia—Carmustine—malignant glioma	0.00233	0.00453	CcSEcCtD
Isosorbide Mononitrate—Mental disorder—Carmustine—malignant glioma	0.00229	0.00444	CcSEcCtD
Isosorbide Mononitrate—Malnutrition—Carmustine—malignant glioma	0.00227	0.00441	CcSEcCtD
Isosorbide Mononitrate—Chills—Temozolomide—malignant glioma	0.00227	0.0044	CcSEcCtD
Isosorbide Mononitrate—Mental disorder—Temozolomide—malignant glioma	0.00221	0.00429	CcSEcCtD
Isosorbide Mononitrate—Back pain—Carmustine—malignant glioma	0.0022	0.00427	CcSEcCtD
Isosorbide Mononitrate—Malnutrition—Temozolomide—malignant glioma	0.0022	0.00426	CcSEcCtD
Isosorbide Mononitrate—Dysgeusia—Temozolomide—malignant glioma	0.00215	0.00418	CcSEcCtD
Isosorbide Mononitrate—Vision blurred—Carmustine—malignant glioma	0.00214	0.00416	CcSEcCtD
Isosorbide Mononitrate—Tremor—Carmustine—malignant glioma	0.00213	0.00413	CcSEcCtD
Isosorbide Mononitrate—Back pain—Temozolomide—malignant glioma	0.00213	0.00413	CcSEcCtD
Isosorbide Mononitrate—Anaemia—Carmustine—malignant glioma	0.0021	0.00408	CcSEcCtD
Isosorbide Mononitrate—Agitation—Carmustine—malignant glioma	0.00209	0.00406	CcSEcCtD
Isosorbide Mononitrate—Vision blurred—Temozolomide—malignant glioma	0.00207	0.00402	CcSEcCtD
Isosorbide Mononitrate—Tremor—Temozolomide—malignant glioma	0.00206	0.004	CcSEcCtD
Isosorbide Mononitrate—Ill-defined disorder—Temozolomide—malignant glioma	0.00204	0.00396	CcSEcCtD
Isosorbide Mononitrate—Leukopenia—Carmustine—malignant glioma	0.00204	0.00395	CcSEcCtD
Isosorbide Mononitrate—Anaemia—Temozolomide—malignant glioma	0.00203	0.00394	CcSEcCtD
Isosorbide Mononitrate—Agitation—Temozolomide—malignant glioma	0.00202	0.00392	CcSEcCtD
Isosorbide Mononitrate—Malaise—Temozolomide—malignant glioma	0.00198	0.00385	CcSEcCtD
Isosorbide Mononitrate—Vertigo—Temozolomide—malignant glioma	0.00197	0.00383	CcSEcCtD
Isosorbide Mononitrate—Leukopenia—Temozolomide—malignant glioma	0.00197	0.00382	CcSEcCtD
Isosorbide Mononitrate—Hypertension—Carmustine—malignant glioma	0.00196	0.00381	CcSEcCtD
Isosorbide Mononitrate—Palpitations—Temozolomide—malignant glioma	0.00194	0.00377	CcSEcCtD
Isosorbide Mononitrate—Chest pain—Carmustine—malignant glioma	0.00194	0.00376	CcSEcCtD
Isosorbide Mononitrate—Myalgia—Carmustine—malignant glioma	0.00194	0.00376	CcSEcCtD
Isosorbide Mononitrate—Anxiety—Carmustine—malignant glioma	0.00193	0.00374	CcSEcCtD
Isosorbide Mononitrate—Cough—Temozolomide—malignant glioma	0.00192	0.00372	CcSEcCtD
Isosorbide Mononitrate—Hypertension—Temozolomide—malignant glioma	0.0019	0.00368	CcSEcCtD
Isosorbide Mononitrate—Confusional state—Carmustine—malignant glioma	0.00187	0.00363	CcSEcCtD
Isosorbide Mononitrate—Arthralgia—Temozolomide—malignant glioma	0.00187	0.00363	CcSEcCtD
Isosorbide Mononitrate—Myalgia—Temozolomide—malignant glioma	0.00187	0.00363	CcSEcCtD
Isosorbide Mononitrate—Anxiety—Temozolomide—malignant glioma	0.00186	0.00362	CcSEcCtD
Isosorbide Mononitrate—Oedema—Carmustine—malignant glioma	0.00186	0.0036	CcSEcCtD
Isosorbide Mononitrate—Discomfort—Temozolomide—malignant glioma	0.00185	0.00359	CcSEcCtD
Isosorbide Mononitrate—Infection—Carmustine—malignant glioma	0.00184	0.00358	CcSEcCtD
Isosorbide Mononitrate—Dry mouth—Temozolomide—malignant glioma	0.00183	0.00355	CcSEcCtD
Isosorbide Mononitrate—Thrombocytopenia—Carmustine—malignant glioma	0.00182	0.00353	CcSEcCtD
Isosorbide Mononitrate—Tachycardia—Carmustine—malignant glioma	0.00181	0.00352	CcSEcCtD
Isosorbide Mononitrate—Confusional state—Temozolomide—malignant glioma	0.00181	0.00351	CcSEcCtD
Isosorbide Mononitrate—Oedema—Temozolomide—malignant glioma	0.00179	0.00348	CcSEcCtD
Isosorbide Mononitrate—Infection—Temozolomide—malignant glioma	0.00178	0.00346	CcSEcCtD
Isosorbide Mononitrate—Anorexia—Carmustine—malignant glioma	0.00177	0.00343	CcSEcCtD
Isosorbide Mononitrate—Nervous system disorder—Temozolomide—malignant glioma	0.00176	0.00341	CcSEcCtD
Isosorbide Mononitrate—Thrombocytopenia—Temozolomide—malignant glioma	0.00176	0.00341	CcSEcCtD
Isosorbide Mononitrate—Skin disorder—Temozolomide—malignant glioma	0.00174	0.00338	CcSEcCtD
Isosorbide Mononitrate—Hypotension—Carmustine—malignant glioma	0.00173	0.00337	CcSEcCtD
Isosorbide Mononitrate—Hyperhidrosis—Temozolomide—malignant glioma	0.00173	0.00336	CcSEcCtD
Isosorbide Mononitrate—Anorexia—Temozolomide—malignant glioma	0.00171	0.00332	CcSEcCtD
Isosorbide Mononitrate—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00169	0.00328	CcSEcCtD
Isosorbide Mononitrate—Insomnia—Carmustine—malignant glioma	0.00168	0.00326	CcSEcCtD
Isosorbide Mononitrate—Paraesthesia—Carmustine—malignant glioma	0.00167	0.00323	CcSEcCtD
Isosorbide Mononitrate—Dyspnoea—Carmustine—malignant glioma	0.00165	0.00321	CcSEcCtD
Isosorbide Mononitrate—Somnolence—Carmustine—malignant glioma	0.00165	0.0032	CcSEcCtD
Isosorbide Mononitrate—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.00163	0.00317	CcSEcCtD
Isosorbide Mononitrate—Insomnia—Temozolomide—malignant glioma	0.00162	0.00315	CcSEcCtD
Isosorbide Mononitrate—Decreased appetite—Carmustine—malignant glioma	0.00161	0.00313	CcSEcCtD
Isosorbide Mononitrate—Paraesthesia—Temozolomide—malignant glioma	0.00161	0.00313	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal disorder—Carmustine—malignant glioma	0.0016	0.00311	CcSEcCtD
Isosorbide Mononitrate—Dyspnoea—Temozolomide—malignant glioma	0.0016	0.0031	CcSEcCtD
Isosorbide Mononitrate—Somnolence—Temozolomide—malignant glioma	0.00159	0.00309	CcSEcCtD
Isosorbide Mononitrate—Constipation—Carmustine—malignant glioma	0.00159	0.00308	CcSEcCtD
Isosorbide Mononitrate—Pain—Carmustine—malignant glioma	0.00159	0.00308	CcSEcCtD
Isosorbide Mononitrate—Dyspepsia—Temozolomide—malignant glioma	0.00158	0.00306	CcSEcCtD
Isosorbide Mononitrate—Decreased appetite—Temozolomide—malignant glioma	0.00156	0.00303	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00155	0.003	CcSEcCtD
Isosorbide Mononitrate—Fatigue—Temozolomide—malignant glioma	0.00155	0.003	CcSEcCtD
Isosorbide Mononitrate—Constipation—Temozolomide—malignant glioma	0.00153	0.00298	CcSEcCtD
Isosorbide Mononitrate—Pain—Temozolomide—malignant glioma	0.00153	0.00298	CcSEcCtD
Isosorbide Mononitrate—Feeling abnormal—Carmustine—malignant glioma	0.00153	0.00297	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal pain—Carmustine—malignant glioma	0.00152	0.00295	CcSEcCtD
Isosorbide Mononitrate—CYP3A4—central nervous system—malignant glioma	0.00151	0.0113	CbGeAlD
Isosorbide Mononitrate—Feeling abnormal—Temozolomide—malignant glioma	0.00148	0.00287	CcSEcCtD
Isosorbide Mononitrate—Abdominal pain—Carmustine—malignant glioma	0.00147	0.00285	CcSEcCtD
Isosorbide Mononitrate—Body temperature increased—Carmustine—malignant glioma	0.00147	0.00285	CcSEcCtD
Isosorbide Mononitrate—Gastrointestinal pain—Temozolomide—malignant glioma	0.00147	0.00285	CcSEcCtD
Isosorbide Mononitrate—Body temperature increased—Temozolomide—malignant glioma	0.00142	0.00275	CcSEcCtD
Isosorbide Mononitrate—Abdominal pain—Temozolomide—malignant glioma	0.00142	0.00275	CcSEcCtD
Isosorbide Mononitrate—Hypersensitivity—Carmustine—malignant glioma	0.00137	0.00265	CcSEcCtD
Isosorbide Mononitrate—Asthenia—Carmustine—malignant glioma	0.00133	0.00258	CcSEcCtD
Isosorbide Mononitrate—Hypersensitivity—Temozolomide—malignant glioma	0.00132	0.00256	CcSEcCtD
Isosorbide Mononitrate—Asthenia—Temozolomide—malignant glioma	0.00129	0.0025	CcSEcCtD
Isosorbide Mononitrate—Diarrhoea—Carmustine—malignant glioma	0.00127	0.00246	CcSEcCtD
Isosorbide Mononitrate—Pruritus—Temozolomide—malignant glioma	0.00127	0.00246	CcSEcCtD
Isosorbide Mononitrate—Dizziness—Carmustine—malignant glioma	0.00123	0.00238	CcSEcCtD
Isosorbide Mononitrate—Diarrhoea—Temozolomide—malignant glioma	0.00123	0.00238	CcSEcCtD
Isosorbide Mononitrate—Dizziness—Temozolomide—malignant glioma	0.00119	0.0023	CcSEcCtD
Isosorbide Mononitrate—Vomiting—Carmustine—malignant glioma	0.00118	0.00229	CcSEcCtD
Isosorbide Mononitrate—Rash—Carmustine—malignant glioma	0.00117	0.00227	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Carmustine—malignant glioma	0.00117	0.00227	CcSEcCtD
Isosorbide Mononitrate—Headache—Carmustine—malignant glioma	0.00116	0.00226	CcSEcCtD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—DOCK6—malignant glioma	0.00114	0.0375	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—DOCK6—malignant glioma	0.00114	0.0375	CbGpPWpGaD
Isosorbide Mononitrate—Vomiting—Temozolomide—malignant glioma	0.00114	0.00221	CcSEcCtD
Isosorbide Mononitrate—Rash—Temozolomide—malignant glioma	0.00113	0.00219	CcSEcCtD
Isosorbide Mononitrate—Dermatitis—Temozolomide—malignant glioma	0.00113	0.00219	CcSEcCtD
Isosorbide Mononitrate—Headache—Temozolomide—malignant glioma	0.00112	0.00218	CcSEcCtD
Isosorbide Mononitrate—Nausea—Carmustine—malignant glioma	0.0011	0.00214	CcSEcCtD
Isosorbide Mononitrate—Nausea—Temozolomide—malignant glioma	0.00107	0.00207	CcSEcCtD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—DOCK6—malignant glioma	0.00102	0.0334	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Liver X Receptor Pathway—CYP2B6—malignant glioma	0.00084	0.0275	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Platelet homeostasis—PTPN11—malignant glioma	0.000764	0.025	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Platelet homeostasis—PTPN11—malignant glioma	0.000764	0.025	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Myometrial Relaxation and Contraction Pathways—YWHAE—malignant glioma	0.000756	0.0248	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—ATP1B2—malignant glioma	0.000693	0.0227	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—ATP1B2—malignant glioma	0.000693	0.0227	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Platelet homeostasis—PTPN11—malignant glioma	0.000681	0.0223	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Myometrial Relaxation and Contraction Pathways—GJA1—malignant glioma	0.000621	0.0203	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—ATP1B2—malignant glioma	0.000618	0.0202	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Oxidation by Cytochrome P450—POR—malignant glioma	0.000568	0.0186	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—ANGPT2—malignant glioma	0.000511	0.0167	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—ANGPT2—malignant glioma	0.000511	0.0167	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Xenobiotics—CYP2B6—malignant glioma	0.000482	0.0158	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—ANGPT2—malignant glioma	0.000455	0.0149	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—HIST1H3B—malignant glioma	0.000442	0.0145	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—HIST1H3B—malignant glioma	0.000442	0.0145	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—MYB—malignant glioma	0.000438	0.0144	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—MYB—malignant glioma	0.000438	0.0144	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Xenobiotics—CYP2C18—malignant glioma	0.000418	0.0137	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—HIST1H3B—malignant glioma	0.000394	0.0129	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Irinotecan Pathway—BCHE—malignant glioma	0.000392	0.0128	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—MYB—malignant glioma	0.000391	0.0128	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Tryptophan metabolism—ASMT—malignant glioma	0.000348	0.0114	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—H3F3A—malignant glioma	0.000342	0.0112	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—H3F3A—malignant glioma	0.000342	0.0112	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2B6—malignant glioma	0.000331	0.0108	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2B6—malignant glioma	0.000316	0.0103	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—H3F3A—malignant glioma	0.000305	0.00997	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Myometrial Relaxation and Contraction Pathways—IL1B—malignant glioma	0.000283	0.00925	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—KNG1—malignant glioma	0.000282	0.00922	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—KNG1—malignant glioma	0.000282	0.00922	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—IFNA2—malignant glioma	0.000276	0.00903	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—IFNA2—malignant glioma	0.000276	0.00903	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—SOD1—malignant glioma	0.000262	0.00856	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—SOD1—malignant glioma	0.000262	0.00856	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—KNG1—malignant glioma	0.000251	0.00822	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—IFNA2—malignant glioma	0.000246	0.00805	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—PTK2—malignant glioma	0.00024	0.00786	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—PTK2—malignant glioma	0.00024	0.00786	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—SOD1—malignant glioma	0.000233	0.00763	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Tryptophan metabolism—CYP2C18—malignant glioma	0.000215	0.00703	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—PTK2—malignant glioma	0.000214	0.00701	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Irinotecan Pathway—APC—malignant glioma	0.000213	0.00697	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—PDGFB—malignant glioma	0.000202	0.00661	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—PDGFB—malignant glioma	0.000202	0.00661	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2B6—malignant glioma	0.0002	0.00656	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Oxidation by Cytochrome P450—CYP2B6—malignant glioma	0.000198	0.00647	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—CAV1—malignant glioma	0.000191	0.00626	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—CAV1—malignant glioma	0.000191	0.00626	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—F2—malignant glioma	0.000182	0.00596	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—FN1—malignant glioma	0.000182	0.00596	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—F2—malignant glioma	0.000182	0.00596	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—FN1—malignant glioma	0.000182	0.00596	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—PDGFB—malignant glioma	0.00018	0.00589	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—PIK3CG—malignant glioma	0.000174	0.0057	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—PIK3CG—malignant glioma	0.000174	0.0057	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C18—malignant glioma	0.000174	0.00569	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—EGF—malignant glioma	0.000172	0.00564	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—EGF—malignant glioma	0.000172	0.00564	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Oxidation by Cytochrome P450—CYP2C18—malignant glioma	0.000171	0.00561	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—PTPN11—malignant glioma	0.000171	0.0056	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—PTPN11—malignant glioma	0.000171	0.0056	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—CAV1—malignant glioma	0.00017	0.00558	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Phase 1 - Functionalization of compounds—CYP2B6—malignant glioma	0.000162	0.00532	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—FN1—malignant glioma	0.000162	0.00531	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—F2—malignant glioma	0.000162	0.00531	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—AKT2—malignant glioma	0.000159	0.00522	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—AKT2—malignant glioma	0.000159	0.00522	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—PIK3CG—malignant glioma	0.000155	0.00508	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—EGF—malignant glioma	0.000153	0.00502	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—PIK3CD—malignant glioma	0.000153	0.00501	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—PIK3CD—malignant glioma	0.000153	0.00501	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—PTPN11—malignant glioma	0.000153	0.00499	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—AKT2—malignant glioma	0.000142	0.00465	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C18—malignant glioma	0.000141	0.00461	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—RAF1—malignant glioma	0.000137	0.00448	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—RAF1—malignant glioma	0.000137	0.00448	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—PIK3CD—malignant glioma	0.000136	0.00447	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—PIK3CB—malignant glioma	0.000133	0.00437	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—PIK3CB—malignant glioma	0.000133	0.00437	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—IL2—malignant glioma	0.000123	0.00401	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—IL2—malignant glioma	0.000123	0.00401	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—RAF1—malignant glioma	0.000122	0.00399	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—PIK3CB—malignant glioma	0.000119	0.00389	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Tryptophan metabolism—CAT—malignant glioma	0.000117	0.00384	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—IL2—malignant glioma	0.000109	0.00358	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Phase 1 - Functionalization of compounds—PTGS1—malignant glioma	0.000107	0.00349	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—VEGFA—malignant glioma	0.000104	0.00341	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—VEGFA—malignant glioma	0.000104	0.00341	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—malignant glioma	0.000101	0.00331	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—VEGFA—malignant glioma	9.28e-05	0.00304	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—KRAS—malignant glioma	8.86e-05	0.0029	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—KRAS—malignant glioma	8.86e-05	0.0029	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—CYP2B6—malignant glioma	8.63e-05	0.00282	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—CYP2B6—malignant glioma	8.51e-05	0.00279	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—PIK3CA—malignant glioma	8.14e-05	0.00266	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—PIK3CA—malignant glioma	8.14e-05	0.00266	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—KRAS—malignant glioma	7.89e-05	0.00258	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—TP53—malignant glioma	7.87e-05	0.00258	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—TP53—malignant glioma	7.87e-05	0.00258	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—CYP2C18—malignant glioma	7.48e-05	0.00245	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—CYP2C18—malignant glioma	7.38e-05	0.00242	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—PIK3CA—malignant glioma	7.25e-05	0.00237	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—TP53—malignant glioma	7.02e-05	0.0023	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A2—Hemostasis—AKT1—malignant glioma	6.65e-05	0.00218	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1B3—Hemostasis—AKT1—malignant glioma	6.65e-05	0.00218	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Tryptophan metabolism—MDM2—malignant glioma	6.47e-05	0.00212	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—GSTT1—malignant glioma	6.05e-05	0.00198	CbGpPWpGaD
Isosorbide Mononitrate—GUCY1A3—Hemostasis—AKT1—malignant glioma	5.92e-05	0.00194	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—PTGS1—malignant glioma	5.67e-05	0.00186	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—RTEL1—malignant glioma	4.24e-05	0.00139	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Biological oxidations—GSTP1—malignant glioma	4.19e-05	0.00137	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metapathway biotransformation—GSTP1—malignant glioma	4.14e-05	0.00135	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—COX8A—malignant glioma	2.44e-05	0.000797	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—ASMT—malignant glioma	2.07e-05	0.000678	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—BCAN—malignant glioma	1.95e-05	0.000637	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—IDH2—malignant glioma	1.57e-05	0.000514	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—CYP2B6—malignant glioma	1.48e-05	0.000483	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—IDH1—malignant glioma	1.35e-05	0.000442	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—SPHK1—malignant glioma	1.31e-05	0.000428	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—CYP2C18—malignant glioma	1.28e-05	0.000419	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—GSTT1—malignant glioma	1.03e-05	0.000339	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—PTGS1—malignant glioma	9.69e-06	0.000317	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—BCHE—malignant glioma	9.01e-06	0.000295	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—SLC5A5—malignant glioma	8.9e-06	0.000292	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—GSTP1—malignant glioma	7.17e-06	0.000235	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—CAT—malignant glioma	6.98e-06	0.000228	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—NCOR1—malignant glioma	6.59e-06	0.000216	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—CAV1—malignant glioma	5.37e-06	0.000176	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—PIK3CG—malignant glioma	4.89e-06	0.00016	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—PPARG—malignant glioma	4.72e-06	0.000155	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—PIK3CD—malignant glioma	4.3e-06	0.000141	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—PIK3CB—malignant glioma	3.75e-06	0.000123	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—PTGS2—malignant glioma	3.72e-06	0.000122	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—PTEN—malignant glioma	3.24e-06	0.000106	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—PIK3CA—malignant glioma	2.29e-06	7.48e-05	CbGpPWpGaD
Isosorbide Mononitrate—CYP3A4—Metabolism—AKT1—malignant glioma	1.87e-06	6.11e-05	CbGpPWpGaD
